Benjamin R Tan
Overview
Explore the profile of Benjamin R Tan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
2001
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
LHotta A, Yan Y, Davis A, Waqar S, Chheda M, Tan B, et al.
Support Care Cancer
. 2023 Mar;
31(4):213.
PMID: 36917417
Purpose: To determine how participation in daily life is impacted during the first six months following a new cancer diagnosis and to identify risk factors for participation restrictions. Patient-reported outcomes...
2.
Chin R, Schiff J, Shetty A, Pedersen K, Aranha O, Huang Y, et al.
Dis Colon Rectum
. 2023 Mar;
66(7):973-982.
PMID: 36876988
Background: Short-course radiation therapy and consolidation chemotherapy with nonoperative intent has emerged as a novel treatment paradigm for patients with rectal cancer, but there are no data on the predictors...
3.
Fracasso P, Goodner S, Wildi J, Naughton M, Linette G, Govindan R, et al.
Am J Clin Oncol
. 2022 Jun;
45(7):294-297.
PMID: 35700081
Background: Human leukocyte antigen (HLA)-DR, a member of the major histocompatibility complex class II antigen family, is a target for antibody-based therapeutics. Apolizumab (Hu1D10, Remitogen), a humanized IgG1 monoclonal anti-HLA-DR...
4.
Chin R, Otegbeye E, Kang K, Chang S, McHenry S, Roy A, et al.
JAMA Netw Open
. 2022 Feb;
5(2):e2146312.
PMID: 35103791
Importance: Short-course radiotherapy and total neoadjuvant therapy (SCRT-TNT) followed by total mesorectal excision (TME) has emerged as a new treatment paradigm for patients with locally advanced rectal adenocarcinoma. However, the...
5.
Chin R, Roy A, Pedersen K, Huang Y, Hunt S, Glasgow S, et al.
Int J Radiat Oncol Biol Phys
. 2021 Oct;
112(3):715-725.
PMID: 34653579
Purpose: This study aimed to determine the clinical efficacy and safety of nonoperative management (NOM) for patients with rectal cancer with a clinical complete response (cCR) after short-course radiation therapy...
6.
Lim K, Opyrchal M, Acharya A, Boice N, Wu N, Gao F, et al.
Eur J Cancer
. 2021 Jul;
154:102-110.
PMID: 34256279
Aim: Aurora kinase A (AURKA) is a pleiotropic serine/threonine kinase that orchestrates mitotic progression. Paclitaxel stabilises microtubules and disrupts mitotic spindle assembly. The combination of AURKA inhibitor (alisertib) plus paclitaxel...
7.
Pellini B, Pejovic N, Feng W, Earland N, Harris P, Usmani A, et al.
JCO Precis Oncol
. 2021 Jul;
5.
PMID: 34250420
Patients And Methods: We applied AVENIO targeted next-generation sequencing to plasma, tumor, and urine samples acquired on the day of curative-intent surgery from 24 prospectively enrolled patients with oligometastatic CRC....
8.
Kim H, Pedersen K, Olsen J, Mutch M, Chin R, Glasgow S, et al.
Clin Colorectal Cancer
. 2021 May;
20(3):e185-e193.
PMID: 34001462
Purpose: Short-course radiation therapy (SCRT) and nonoperative management are emerging paradigms for rectal cancer treatment. This clinical trial is the first to evaluate SCRT followed by chemotherapy as a nonoperative...
9.
Li L, Zhang X, Wang X, Kim S, Herndon J, Becker-Hapak M, et al.
Genome Med
. 2021 Apr;
13(1):56.
PMID: 33879241
Background: Preclinical studies and early clinical trials have shown that targeting cancer neoantigens is a promising approach towards the development of personalized cancer immunotherapies. DNA vaccines can be rapidly and...
10.
Park H, Jin R, Wang-Gillam A, Suresh R, Rigden C, Amin M, et al.
JAMA Oncol
. 2020 May;
6(8):1231-1240.
PMID: 32469386
Importance: Standard first-line regimens for patients with metastatic gastroesophageal adenocarcinomas have an approximate 40% objective response rate (ORR). The combination of leucovorin, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) has been efficacious...